Bonsu Ku

Bonsu Ku

Auto-generated profile, based on publicly available information

Bonsu Ku

Orphan Disease Therapeutic Target Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2006 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
CLChengyu Liang
Chengyu Liang
PFPinghui Feng
Pinghui Feng
BKBonsu Ku
Bonsu Ku
IDIris Dotan
Iris Dotan
DCDan Canaani
Dan Canaani
JJJae U. Jung
Jae U. Jung

9 November 2010 in Cell Research
Verified
Journal Article
Closed access
BKBonsu Ku
Bonsu Ku
CLChengyu Liang
Chengyu Liang
JJJae U Jung
Jae U Jung
BOByung-Ha Oh
Byung-Ha Oh

1 February 2008 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
BKBonsu Ku
Bonsu Ku
JWJae-Sung Woo
Jae-Sung Woo
CLChengyu Liang
Chengyu Liang
KLKwang-Hoon Lee
Kwang-Hoon Lee
HHHyang-Suk Hong
Hyang-Suk Hong
BOByung-Ha Oh
Byung-Ha Oh
All gammaherpesviruses express homologues of antiapoptotic B-cell lymphoma-2 (BCL-2) to counter the clearance of infected cells by host antiviral defense machineries. To gain insights into the action mechanisms of these viral BCL-2 proteins, we carried out structural and biochemical analyses on the interactions of M11, a viral BCL-2 of murine γ-herpesvirus 68, with a fragment of proautophagic Beclin1 and BCL-2 homology 3 (BH3) domain-containing peptides derived from an array of proapoptotic BCL-2 family proteins. Mainly through hydrophobic interactions, M11 bound the BH3-like domain of Beclin1 with a dissociation constant of 40 nanomole, a markedly tighter affinity compared to the 1.7 micromolar binding affinity between cellular BCL-2 and Beclin1. Consistently, M11 inhibited autophagy more efficiently than BCL-2 in NIH3T3 cells. M11 also interacted tightly with a BH3 domain peptide of BAK and those of the upstream BH3-only proteins BIM, BID, BMF, PUMA, and Noxa, but weakly with that of BAX. These results collectively suggest that M11 potently inhibits Beclin1 in addition to broadly neutralizing the proapoptotic BCL-2 family in a similar but distinctive way from cellular BCL-2, and that the Beclin1-mediated autophagy may be a main target of the virus. In higher animals, defective or surplus cells are removed by a process known as apoptosis. On the other hand, defective or damaged cellular components are removed by a process known as autophagy. These two destructive processes are indispensable for the survival and development of an organism. While apoptosis is known as a central host defense mechanism that removes virus-infected cells, the role of autophagy against viral infection has recently emerged. Many viruses express an armory of viral proteins that counteract cell death–mediated innate immune control. One such protein is a homologue of the cellular BCL-2 protein that suppresses apoptosis through inhibitory binding to apoptosis-promoting proteins. Murine γ-herpesvirus 68 also encodes a viral BCL-2, known as M11. In this study, we quantitatively measured the binding affinity of M11 for its potential cellular targets, including ten different proapoptotic proteins and the proautophagic protein Beclin1. We found that M11 neutralizes the proapoptotic proteins broadly rather than selectively to suppress apoptosis. Surprisingly, M11 bound to Beclin1 with the highest affinity, which correlated with its strong antiautophagic activity in cells. These data suggest that M11 suppresses not only apoptosis but also autophagy potently, which ultimately contributes to the viral chronic infection.

1 August 2016 in Cancer Cell
Verified
Journal Article
Closed access
YCYoung Chan Chae
Young Chan Chae
VVValentina Vaira
Valentina Vaira
MCM. Cecilia Caino
M. Cecilia Caino
HTHsin-Yao Tang
Hsin-Yao Tang
JSJae Ho Seo
Jae Ho Seo
DADario C. Altieri
Dario C. Altieri

1 January 2009 in Cell
Verified
Journal Article
Closed access
JWJae-Sung Woo
Jae-Sung Woo
JLJae-Hong Lim
Jae-Hong Lim
HSHo-Chul Shin
Ho-Chul Shin
MSMin-Kang Suh
Min-Kang Suh
BKBonsu Ku
Bonsu Ku
BOByung-Ha Oh
Byung-Ha Oh

29 June 2014 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
SPSuk-Youl Park
Suk-Youl Park
JPJung-Eun Park
Jung-Eun Park
TKTae-Sung Kim
Tae-Sung Kim
JKJu Hee Kim
Ju Hee Kim
MKMi-Jeong Kwak
Mi-Jeong Kwak
KLKyung-sang Lee
Kyung-sang Lee
Plk4 regulates centriole duplication. Two centrosomal scaffold proteins, Cep192 and Cep152, are shown to interact with Plk4 in a temporally and spatially regulated manner, and structural analyses reveal that these interactions are mutually exclusive. Polo-like kinase 4 (Plk4) is a key regulator of centriole duplication, an event critical for the maintenance of genomic integrity. We show that Plk4 relocalizes from the inner Cep192 ring to the outer Cep152 ring as newly recruited Cep152 assembles around the Cep192-encircled daughter centriole. Crystal-structure analyses revealed that Cep192- and Cep152-derived peptides bind the cryptic polo box (CPB) of Plk4 in opposite orientations and in a mutually exclusive manner. The Cep152 peptide bound to the CPB markedly better than did the Cep192 peptide and effectively 'snatched' the CPB away from a preformed CPB–Cep192 peptide complex. A cancer-associated Cep152 mutation impairing the Plk4 interaction induced defects in procentriole assembly and chromosome segregation. Thus, Plk4 is intricately regulated in time and space through ordered interactions with two distinct scaffolds, Cep192 and Cep152, and a failure in this process may lead to human cancer.